New trends in controlled drug delivery to posterior segment;Cesión controlada de fármacos en el segmento posterior. Nuevas tendencias

Archivos de la Sociedad Espanola de Oftalmologia

Volumn 82, Issue 1, 2007, Pages 3-6

  Herrero Vanrell, R ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOROID; DRUG ADMINISTRATION ROUTE; EDITORIAL; EYE DISEASE; HUMAN; OPTIC NERVE; RETINA; VITREOUS BODY;

CHOROID; DRUG ADMINISTRATION ROUTES; EYE DISEASES; HUMANS; OPTIC NERVE; RETINA; VITREOUS BODY;

EID: 34447532214     PISSN: 03656691     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (6)

1. Geroski DH, Edelhauser HF. Drug delivery for posterior segment eye disease. Invest Ophthalmol Vis Sci 2000; 41: 961-964.
2. Wang N, Wu XS, Li C, Feng MF. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers: I. Synthesis and characterization. J Biomater Sci Polym Ed 2000; 11: 301-318.
3. Ambati J, Canakis CS, Miller JW, Gragoudas ES, Edwards A, Weissgold DJ, et al. Diffusion of high molecular weight compounds through sclera. Invest Ophthalmol Vis Sci 2000; 41: 1181-1185.
4. Herrero-Vanrel R, Refojo MF. Biodegradable microspheres for vitreoretinal drug delivery. Adv Drug Deliv Rev 2001; 52: 5-16.
5. Lee SB, Geroski DH, Prausnitz MR, Edelhauser HF. Drug delivery through the sclera: effects of thickness, hydration, and sustained release systems. Exp Eye Res 2004; 78: 599-607.
6. Kompella UB, Bandi N, Ayalasomayajula SP. Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression. Invest Ophthalmol Vis Sci 2003; 44: 1192-1201.